Literature DB >> 30958537

Grainyhead-like Protein 2: The Emerging Role in Hormone-Dependent Cancers and Epigenetics.

Rebecca M Reese1, Melissa M Harrison2, Elaine T Alarid1.   

Abstract

In mammals, the grainyhead-like transcription factor (GRHL) family is composed of three nuclear proteins that are responsible for driving epithelial cell fate: GRHL1, GRHL2, and GRHL3. GRHL2 is important in maintaining proper tubulogenesis during development and in suppressing the epithelial-to-mesenchymal transition. Within the last decade, evidence indicates both tumor-suppressive and oncogenic roles for GRHL2 in various types of cancers. Recent studies suggest that GRHL2 may be especially important in hormone-dependent cancers, as correlative relationships exist between GRHL2 and various steroid receptors, such as the androgen and estrogen receptors. Acting as a pioneer factor and coactivator, GRHL2 may directly affect steroid receptor transcriptional activity. This review will highlight recent discoveries of GRHL2 activity in cancer and in maintaining the epithelial state, while also exploring recent literature on the role of GRHL2 in hormone-dependent cancers and epigenetics.
Copyright © 2019 Endocrine Society.

Entities:  

Year:  2019        PMID: 30958537     DOI: 10.1210/en.2019-00213

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

Review 1.  Grainyhead-like transcription factors in cancer - Focus on recent developments.

Authors:  Grzegorz Kotarba; Agnieszka Taracha-Wisniewska; Tomasz Wilanowski
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-02

2.  GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression.

Authors:  Rebecca M Reese; Kyle T Helzer; Kaelyn O Allen; Christy Zheng; Natalia Solodin; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2022-08-29       Impact factor: 5.069

Review 3.  Pioneering the developmental frontier.

Authors:  Elizabeth D Larson; Audrey J Marsh; Melissa M Harrison
Journal:  Mol Cell       Date:  2021-03-08       Impact factor: 17.970

4.  Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer.

Authors:  Edmond M Kwan; Heidi Fettke; Megan Crumbaker; Maria M Docanto; Sarah Q To; Patricia Bukczynska; Andrew Mant; Nicole Ng; Siavash Foroughi; Lisa-Jane K Graham; Anne-Maree Haynes; Sarah Azer; Lisi Elizabeth Lim; Eva Segelov; Kate Mahon; Ian D Davis; Phillip Parente; Carmel Pezaro; Tilman Todenhöfer; Niranjan Sathianathen; Christine Hauser; Lisa G Horvath; Anthony M Joshua; Arun A Azad
Journal:  Transl Androl Urol       Date:  2021-04

Review 5.  Estrogenic control of mitochondrial function.

Authors:  Carolyn M Klinge
Journal:  Redox Biol       Date:  2020-01-23       Impact factor: 11.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.